Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

CAPS Rating: 2 out of 5

A clinical-stage biopharmaceutical company focused on discovering, developing and commercializing oral drugs in four major therapeutic areas: cardiovascular, central nervous system, inflammatory and metabolic diseases.

Recs

0
Player Avatar Brent2223 (48.19) Submitted: 1/20/2011 12:36:28 PM : Outperform Start Price: $1.97 ARNA Score: +201.23

obesity play, lottery ticket.

Featured Broker Partners


Advertisement